✦ LIBER ✦

Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: A phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

✍ Scribed by Michael Leahy; Isabelle Ray-Coquard; Jaap Verweij; Axel Le Cesne; Florence Duffaud; Pancras C.W. Hogendoorn; Camilla Fowst; Christine de Balincourt; Eugenio Donato di Paola; Martine van Glabbeke; Ian Judson; Jean-Yves Blay

Book ID: 116429177
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 166 KB
Volume: 43
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2006.09.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Temozolomide in adult patients with adva

Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

✍ P.J Woll; I Judson; S.M Lee; S Rodenhuis; O.S Nielsen; J.M Buesa; P.C Lorigan; S 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Exatecan in pretreated adult patients wi

Exatecan in pretreated adult patients with advanced soft tissue sarcoma: Results of a phase II – Study of the EORTC Soft Tissue and Bone Sarcoma Group

✍ P. Reichardt; O.S. Nielsen; S. Bauer; J.T. Hartmann; P. Schöffski; T.B. Christen 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Performance status is the most powerful

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcomaThe European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study

✍ Penel, N; Glabbeke, M V; Mathoulin-Pelissier, S; Judson, I; Sleijfer, S; Bui, B; 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 356 KB

Doxorubicin plus ifosfamide with rhGM-CS

Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma Group

✍ W. P. Steward; J. Verweij; R. Somers; G. Blackledge; M. Clavel; A. T. Van Ooster 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 561 KB

Randomised phase II trial of pegylated l

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group

✍ I Judson; J.A Radford; M Harris; J.-Y Blay; Q van Hoesel; A le Cesne; A.T van Oo 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Surgical treatment of lung metastases: T

Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients

✍ Albert N. van Geel; Ugo Pastorino; Karl W. Jauch; Ian R. Judson; Frits van Coevo 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 704 KB

Several reports have shown a prolonged survival after surgical treatment of pulmonary metastases from soft tissue sarcomas. However, it is still unclear which prognostic factors predict a favorable outcome. Series are not comparable and the data are conflicting. Therefore, a multi-institutional stud